- Home
- VLTO vs DXCM Comparison
VLTO vs DXCM Comparison
Compare VLTO & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLTO
- DXCM
- Stock Information
- Founded
- VLTO 2023
- DXCM 1999
- Country
- VLTO United States
- DXCM United States
- Employees
- VLTO N/A
- DXCM N/A
- Industry
- VLTO Electrical Products
- DXCM Medical/Dental Instruments
- Sector
- VLTO Industrials
- DXCM Health Care
- Exchange
- VLTO Nasdaq
- DXCM Nasdaq
- Market Cap
- VLTO 26.5B
- DXCM 31.7B
- IPO Year
- VLTO N/A
- DXCM 2005
- Fundamental
- Price
- VLTO $109.15
- DXCM $77.60
- Analyst Decision
- VLTO Buy
- DXCM Strong Buy
- Analyst Count
- VLTO 7
- DXCM 19
- Target Price
- VLTO $114.00
- DXCM $99.89
- AVG Volume (30 Days)
- VLTO 940.0K
- DXCM 4.1M
- Earning Date
- VLTO 10-22-2025
- DXCM 10-23-2025
- Dividend Yield
- VLTO 0.40%
- DXCM N/A
- EPS Growth
- VLTO 12.21
- DXCM N/A
- EPS
- VLTO 3.58
- DXCM 1.43
- Revenue
- VLTO $5,362,000,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- VLTO $8.01
- DXCM $17.03
- Revenue Next Year
- VLTO $5.46
- DXCM $15.59
- P/E Ratio
- VLTO $30.46
- DXCM $53.30
- Revenue Growth
- VLTO 5.61
- DXCM 9.30
- 52 Week Low
- VLTO $83.87
- DXCM $57.52
- 52 Week High
- VLTO $115.00
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- VLTO 56.68
- DXCM 46.90
- Support Level
- VLTO $104.76
- DXCM $75.39
- Resistance Level
- VLTO $109.86
- DXCM $81.64
- Average True Range (ATR)
- VLTO 1.52
- DXCM 2.23
- MACD
- VLTO 0.10
- DXCM 0.07
- Stochastic Oscillator
- VLTO 75.09
- DXCM 49.82
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.